This study examined how hemagglutinins (HA) from the 2.3.4.4b H5N1 lineage achieve binding to human respiratory tract receptors. The authors focused on a widely discussed substitution, Q226L, previously suggested to switch HA preference from avian-type to human-type receptors. Because circulating H5Nx viruses have caused repeated zoonotic spillovers to mammals, including cattle, the team sought to determine whether Q226L alone is sufficient for HA binding to human respiratory tissue or whether additional substitutions and HA features are required.
The report emphasizes testing that goes beyond synthetic glycan assays by assessing binding directly to sections of the human trachea, providing a tissue-based perspective on receptor interactions that may better reflect in vivo binding potential.
The study evaluated the H5TX Q226L mutant derived from A/Texas/34 H5N1 alongside other HA mutants. The investigators also examined an H5FR Q226L mutant from A/duck/France/161108/16 H5N8. Testing included binding assays to synthetic glycans as well as binding to human tracheal tissue sections.
Additionally, the authors considered HA features beyond single amino acid substitutions, notably the presence of a multibasic cleavage site, a motif found in highly pathogenic influenza strains, and assessed how this motif correlated with receptor-binding properties in the H5FR Q226L context.
In glycan-based assays, the H5TX Q226L substitution allowed the HA to recognize human-type receptors, consistent with prior suggestions that Q226L shifts receptor preference. However, when binding was tested on sections of the human trachea, the H5TX Q226L mutant did not show the same capacity to attach to human respiratory tract tissue.
From these observations the authors conclude that, although Q226L enables recognition of human-type sialylated glycans in vitro, a single Q226L mutation is insufficient for HA from this 2.3.4.4b H5N1 background to bind human respiratory tract tissue. Therefore, additional amino acid changes or contextual HA features are necessary to mediate attachment to human airway epithelium.
The study reports altered receptor-binding specificity for the H5FR Q226L mutant. This change in specificity was associated with the presence of a multibasic cleavage site in the HA of that strain. The authors highlight this association to indicate that determinants of receptor binding can be multifactorial and that cleavage site motifs may influence HA behavior beyond their established role in pathogenicity.
Combining the glycan assay and tissue-binding data, the authors infer that gaining the ability to bind the human respiratory tract is not a simple, single-point mutation event for these 2.3.4.4b H5Nx hemagglutinins. Instead, the transition toward human-type receptor binding likely requires multiple amino acid substitutions and may be modulated by other HA structural elements, including cleavage site composition.
The study underscores that findings from synthetic glycan analyses should be corroborated with tissue-based approaches because glycan recognition alone did not predict tissue attachment in the H5TX Q226L example.
These results have relevance for public health surveillance of circulating H5Nx viruses. The evidence that multiple mutations and HA-contextual features are needed to confer tissue binding suggests that monitoring for single substitutions such as Q226L is insufficient to predict human adaptation risk. The authors recommend strain-specific evaluation using complementary methods, including tissue-based testing, to better assess the potential for human infection and the early stages of host-range expansion.
The study frames its findings within the context of zoonotic spillover events and notes that, to date, no sustained human-to-human transmission of these viruses has been observed; however, understanding receptor-binding determinants remains critical to assessing emergence risk.
The abstract and article text emphasize methodological breadth—using both synthetic glycans and tissue sections—as essential to capture differences in receptor-binding behavior. The authors call for testing individual strains with multiple approaches because glycan-binding data alone may overestimate the extent to which HA can attach to human respiratory tissue. Specific experimental details, quantitative binding data, and broader mutational scans were not reported in the abstract and should be consulted in the full text for comprehensive evaluation.
Overall, the study provides evidence that evolution toward human-type receptor binding in currently circulating 2.3.4.4b H5N1 and related H5Nx viruses will likely require a constellation of changes in HA rather than a single canonical substitution.